Mass. Biotech Co. Liable For CEO Duping Investors, SEC Says

By Aaron Leibowitz · July 23, 2019, 7:11 PM EDT

A Massachusetts cancer diagnostics company whose founder was sentenced to 27 months in prison for squandering most of the $1.2 million he raised from investors should be held liable for his...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

United States Securities and Exchange Commission v. Muraca et al

Case Number

Court

Massachusetts

Nature of Suit

Securities/Commodities

Date Filed

July 31, 2017

Recent Articles By Aaron

September 26, 2019
Mass. Wants New Ruling In ACA Birth Control Coverage Suit
September 23, 2019
Mass. Hospital Can't Nix Arbitrator's Reinstatement Of Nurse
September 20, 2019
FDCA Doesn't Apply To Convicted NECC Workers, Judge Told
September 19, 2019
Cynosure Says Mass. Law Allows No 'Re-Do' Of False Ad Suit
September 10, 2019
Weil Downplayed Atty Conflict, Convicted Insys Exec Says
September 05, 2019
Philip Morris Tells Mass. Jury Woman's Smoking Was Choice
September 04, 2019
Psychiatrist Retaliated After Legal Threat, 1st Circ. Told
August 16, 2019
Weil's Bid To Intervene In Insys Conflict Faces Opposition
August 12, 2019
Feds Say Insys Needs Consent To Sell Gov't Deals In Ch. 11
August 08, 2019
Gov't Fights Insys Founder's Bid To Delay Sentencing